<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" 'JATS-journalpublishing1-3-mathml3.dtd'>
<article article-type="editorial" dtd-version="1.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1748172</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2025.1748172</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Editorial</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Ubiquitin proteasome system (UPS) and ubiquitin-independent proteasome-mediated proteolysis (UIPP) crosstalk in development and disease</article-title>
<alt-title alt-title-type="left-running-head">Sharon and Stohwasser</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2025.1748172">10.3389/fcell.2025.1748172</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Sharon</surname>
<given-names>Michal</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2411964"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Stohwasser</surname>
<given-names>Ralf</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2394827"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing - original draft</role>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<institution>Department of Biomolecular Sciences, Weizmann Institute of Science</institution>, <city>Rehovot</city>, <country country="IL">Israel</country>
</aff>
<aff id="aff2">
<label>2</label>
<institution>Institute of Biotechnology, Biochemistry, Faculty of Environmental and Natural Sciences and Faculty of Health Science Brandenburg (coopted), Brandenburg University of Technology, Cottbus-Senftenberg</institution>, <city>Senftenberg</city>, <country country="DE">Germany</country>
</aff>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: Michal Sharon, <email xlink:href="mailto:michal.sharon@weizmann.ac.il">michal.sharon@weizmann.ac.il</email>; Ralf Stohwasser, <email xlink:href="mailto:ralf.stohwasser@b-tu.de">ralf.stohwasser@b-tu.de</email>
</corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2025-12-10">
<day>10</day>
<month>12</month>
<year>2025</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2025</year>
</pub-date>
<volume>13</volume>
<elocation-id>1748172</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>11</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Sharon and Stohwasser.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Sharon and Stohwasser</copyright-holder>
<license>
<ali:license_ref start_date="2025-12-10">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<kwd-group>
<kwd>aging</kwd>
<kwd>caspase-like activity</kwd>
<kwd>proteasome</kwd>
<kwd>condensates</kwd>
<kwd>signalosome</kwd>
<kwd>neurodegeneration</kwd>
<kwd>stress granules</kwd>
<kwd>ubiquitin-independent proteasomal protein degradation</kwd>
</kwd-group>
<funding-group>
<funding-statement>The authors declare that no financial support was received for the research and/or publication of this article.</funding-statement>
</funding-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="3"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Signaling</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes notes-type="frontiers-research-topic">
<p>Editorial on the Research Topic <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/research-topics/62657">Ubiquitin proteasome system (UPS) and ubiquitin-independent proteasome-mediated proteolysis (UIPP) crosstalk in development and disease</ext-link>
</p>
</notes>
</front>
<body>
<p>The Ubiquitin&#x2013;Proteasome System (UPS) and Ubiquitin-Independent Proteasomal Protein Degradation (UIPP) represent the two principal proteasome-based pathways of intracellular protein turnover. These processes are intricately interconnected through their shared use of distinct 20S proteasome isoforms, including the constitutive (c20S), immunoproteasome (i20S), and tissue-specific variants, and their regulation by diverse proteasome activators (PAs) and inhibitors (PIs). Such diversity underlies functional specialization across cellular contexts, from non-lymphatic and interferon-untreated tissues (c20S) to lymphatic or interferon-&#x3b3;-induced environments (i20S), and even to specialized forms such as neuron-associated membrane proteasomes or thymus-specific complexes (t20S). While multiple recent Frontiers Research Topics and other publications have extensively explored facets of the UPS, the UIPP and its crosstalk with the UPS, particularly under cellular stress and disease conditions, remain less well understood. The four contributions in this Research Topic aim to advance our understanding of these intertwined pathways and their roles in maintaining proteostasis.</p>
<p>In their opinion article, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2024.1496862">Dubiel and Dubiel</ext-link> present an insightful comparison between the LID complex of the proteasomal 19S regulatory particle and the COP9 signalosome (CSN). Both complexes share remarkable evolutionary and structural similarities, most notably between RPN11 in the LID and its paralog CSN5 in the CSN, each containing a metallo-deubiquitylase active site. While RPN11 removes ubiquitin chains from proteasome-bound substrates, CSN5 mediates deneddylation of cullins, thereby controlling the activity of cullin&#x2013;RING E3 ubiquitin ligases (CRLs). These complexes exhibit a striking one-to-one correspondence across most subunits and share a comparable overall architecture that extends beyond their canonical deubiquitylating and deneddylating functions. Building on this analogy, the authors raise an intriguing question: could these signalosome&#x2013;proteasome paralogs reciprocally regulate each other&#x2019;s activity? Addressing this possibility will require a better understanding of the dissociation dynamics and subunit exchange between LID and CSN. Indeed, activity assays and co-immunoprecipitation studies have demonstrated partial interchangeability between the two complexes <italic>in vitro</italic>; however, whether the LID can substitute for the CSN under physiological conditions remains to be determined.</p>
<p>The involvement of UIPP degradation in neurodegenerative disorders is comprehensively reviewed by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2024.1531797">Church and Margolis</ext-link>. Their concise review focuses on UIPP mechanisms and the emerging roles these pathways play in the context of neurodegeneration. The authors discuss the diversity of ubiquitin-independent proteasomal pathways, emphasizing substrate recognition, targeting, the contribution of regulatory cofactors such as PA700, PA28, PA200, PI31, and the recently identified CCR family, which allosterically modulate uncapped 20S proteasome activity. Specialized proteasome assemblies including the immunoproteasome (i20S), neuronal membrane proteasomes, extracellular proteasomes, and hybrid proteasome complexes are also explored. These systems are examined within the broader context of aging, oxidative stress, protein aggregation, and age-associated neurodegenerative diseases, with particular attention to Alzheimer&#x2019;s, Huntington&#x2019;s, and Parkinson&#x2019;s diseases. The review underscores that a mechanistic understanding of UIPP function and regulation in neuronal health and degeneration is essential for developing novel therapeutic strategies aimed at selectively targeting this degradation pathway in neurodegenerative disease.</p>
<p>Over the past decade, the study of protein condensates has attracted considerable attention. These non-membrane-bound, dynamic pseudo-compartments arise through the aggregation or phase separation of proteins within the cytoplasm or nucleus. Two articles in this Research Topic address protein turnover within such condensates, including liquid&#x2013;liquid phase-separated structures like stress granules (SGs) and proteasome condensates. These so-called non-canonical UPS (nUPS) assemblies are associated with a wide range of stress conditions, such as nanoparticle exposure, inflammation, senescence, DNA damage, hyperosmotic stress, and amino acid starvation as reviewed by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2025.1523382">Ernst and Enenkel</ext-link>. Proteasome-containing condensates often include additional UPS components and may harbor condensate-specific proteolytic systems. They have been identified at the nuclear periphery and in the cytoplasm of mammalian cells, as well as in yeast, where they form proteasome storage granules (PSGs) that are reversible and contribute to stress resistance and enhanced cellular fitness during aging. Recent studies on proteasome condensates link their formation and dynamics to metabolic changes, suggesting an adaptive role of proteasome organization in maintaining proteostasis under stress.</p>
<p>Proteasome activities serve distinct and context-dependent roles in maintaining cellular homeostasis. Historically, these activities were characterized using fluorogenic peptide substrates, but more recent studies employing physiological protein substrates and mass spectrometry have revealed a more nuanced picture of their functions. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2025.1570499">Steinberger et al.</ext-link> explore the functional relevance of the caspase-like activity and its role in cellular adaptation to stress. Using engineered cell lines lacking this specific activity, the authors show that the mutant cells display slower proliferation, heightened stress sensitivity, and activation of the unfolded protein response (UPR), as evidenced by elevated stress markers. This observation is particularly intriguing, as the chymotrypsin-like activity is typically considered the dominant and rate-limiting. Moreover, associated regulatory particles are known to allosterically influence the catalytic properties and cleavage preferences of the 20S core, further shaping proteasomal activity. The findings by Steinberger and colleagues thus add a valuable cell-biological dimension to our understanding of proteasome regulation, emphasizing the specialized contributions of individual proteolytic activities to cellular stress responses and protein quality control.</p>
<p>In summary, the four contributions presented in this Research Topic highlight the growing complexity and versatility of proteasome biology. Collectively, they emphasize the multifaceted regulation of proteasomal activity and its central role in sustaining cellular proteostasis across diverse physiological and pathological contexts. This Research Topic reinforces the view that the proteasome is far from a static proteolytic machine; rather, it is a highly dynamic and adaptable system, continually reshaped by cellular context, stress, and evolution, remaining an enduring and fertile area of discovery in cell biology.</p>
</body>
<back>
<sec sec-type="author-contributions" id="s1">
<title>Author contributions</title>
<p>MS: Conceptualization, Writing &#x2013; review and editing. RS: Writing &#x2013; review and editing, Conceptualization, Writing &#x2013; original draft.</p>
</sec>
<sec sec-type="COI-statement" id="s3">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="ai-statement" id="s4">
<title>Generative AI statement</title>
<p>The authors declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="s5">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<fn-group>
<fn fn-type="custom" custom-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/125345/overview">Ana Cuenda</ext-link>, Spanish National Research Council (CSIC), Spain</p>
</fn>
</fn-group>
</back>
</article>